4.8 Article

Role of sulfiredoxin as a peroxiredoxin-2 denitrosylase in human iPSC-derived dopaminergic neurons

Publisher

NATL ACAD SCIENCES
DOI: 10.1073/pnas.1608784113

Keywords

sulfiredoxin; peroxiredoxin; denitrosylase; iPSC-derived dopaminergic neuron; S-nitrosylation

Funding

  1. NIH [R01 NS086890, DP1 DA041722, P01 HD29587]
  2. La Jolla Interdisciplinary Neuroscience Center [P30 NS076411]
  3. Michael J. Fox Foundation

Ask authors/readers for more resources

Recent studies have pointed to protein S-nitrosylation as a critical regulator of cellular redox homeostasis. For example, S-nitrosylation of peroxiredoxin-2 (Prx2), a peroxidase widely expressed in mammalian neurons, inhibits both enzymatic activity and protective function against oxidative stress. Here, using in vitro and in vivo approaches, we identify a role and reaction mechanism of the reductase sulfiredoxin (Srxn1) as an enzyme that denitrosylates (thus removing - SNO) from Prx2 in an ATP-dependent manner. Accordingly, by decreasing S-nitrosylated Prx2 (SNO-Prx2), overexpression of Srxn1 protects dopaminergic neural cells and human-induced pluripotent stem cell (hiPSC)-derived neurons from NO-induced hypersensitivity to oxidative stress. The pathophysiological relevance of this observation is suggested by our finding that SNO-Prx2 is dramatically increased in murine and human Parkinson's disease (PD) brains. Our findings therefore suggest that Srxn1 may represent a therapeutic target for neurodegenerative disorders such as PD that involve nitrosative/oxidative stress.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

NitroSynapsin ameliorates hypersynchronous neural network activity in Alzheimer hiPSC models

Swagata Ghatak, Nima Dolatabadi, Richard Gao, Yin Wu, Henry Scott, Dorit Trudler, Abdullah Sultan, Rajesh Ambasudhan, Tomohiro Nakamura, Eliezer Masliah, Maria Talantova, Bradley Voytek, Stuart A. Lipton

Summary: Early stages of human Alzheimer's disease (AD) show hyperexcitability in the brain, leading to extensive synapse loss and cognitive dysfunction, with no current disease-modifying therapy available. Utilizing human iPSC models may be a valuable tool for screening drugs to treat hyperexcitability and synaptic damage in AD, potentially increasing the chances of success in treatment.

MOLECULAR PSYCHIATRY (2021)

Review Pharmacology & Pharmacy

Novel Therapeutic Approach for Excitatory/Inhibitory Imbalance in Neurodevelopmental and Neurodegenerative Diseases

Swagata Ghatak, Maria Talantova, Scott R. McKercher, Stuart A. Lipton

Summary: The balance between excitation and inhibition in a neuronal network, known as excitatory/inhibitory (E/I) balance, is crucial for normal brain function. In pathological conditions, this balance can be disrupted, leading to E/I imbalance and network dysfunction. Developing therapies to rebalance neural networks is important for improving neurological function in diseases associated with E/I imbalance.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 61, 2021 (2021)

Article Neurosciences

α-Synuclein Oligomers Induce Glutamate Release from Astrocytes and Excessive Extrasynaptic NMDAR Activity in Neurons, Thus Contributing to Synapse Loss

Dorit Trudler, Sara Sanz-Blasco, Yvonne S. Eisele, Swagata Ghatak, Karthik Bodhinathan, Mohd Waseem Akhtar, William P. Lynch, Juan C. Pina-Crespo, Maria Talantova, Jeffery W. Kelly, Stuart A. Lipton

Summary: In Parkinson's disease, synaptic and neuronal loss are prominent features. The study reveals that alpha Syn oligomers induce excessive glutamate release from astrocytes, activating NMDARs on neurons and leading to synaptic damage. However, the drug NitroSynapsin shows promise in protecting synapses from alpha Syn-induced damage.

JOURNAL OF NEUROSCIENCE (2021)

Article Multidisciplinary Sciences

Noncanonical transnitrosylation network contributes to synapse loss in Alzheimer's disease

Tomohiro Nakamura, Chang-ki Oh, Lujian Liao, Xu Zhang, Kevin M. Lopez, Daniel Gibbs, Amanda K. Deal, Henry R. Scott, Brian Spencer, Eliezer Masliah, Robert A. Rissman, John R. Yates, Stuart A. Lipton

Summary: This study describes mechanistically distinct enzymes that can mediate a series of redox reactions and lead to synapse loss in patients with Alzheimer's disease. These enzymes can form a separate network for aberrant transnitrosylation, which may not be effectively countered by natural selection in the post-reproductive period.

SCIENCE (2021)

Article Multidisciplinary Sciences

S-nitrosylated TDP-43 triggers aggregation, cell-to-cell spread, and neurotoxicity in hiPSCs and in vivo models of ALS/FTD

Elaine Pirie, Chang-Ki Oh, Xu Zhang, Xuemei Han, Piotr Cieplak, Henry R. Scott, Amanda K. Deal, Swagata Ghatak, Fernando J. Martinez, Gene W. Yeo, John R. Yates, Tomohiro Nakamura, Stuart A. Lipton

Summary: This study reveals that environmentally induced nitrosative stress can trigger protein aggregation and cell-to-cell spread, leading to abnormal aggregation of TDP-43 in ALS/FTD. These processes also interfere with neuronal function, contributing to the progression of the diseases.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Biochemistry & Molecular Biology

Protein Transnitrosylation Signaling Networks Contribute to Inflammaging and Neurodegenerative Disorders

Tomohiro Nakamura, Chang-ki Oh, Xu Zhang, Steven R. Tannenbaum, Stuart A. Lipton

Summary: Physiological concentrations of nitric oxide and related reactive nitrogen species play important roles in mediating signaling pathways in the nervous system. S-nitrosylation, particularly through transnitrosylation, is a critical chemical mechanism for transduction of redox-mediated events. Future studies should focus on understanding how transnitrosylation regulates various neuronal attributes in aging, inflammation, and neurodegenerative diseases.

ANTIOXIDANTS & REDOX SIGNALING (2021)

Article Neurosciences

TCA cycle metabolic compromise due to an aberrant S-nitrosoproteome in HIV-associated neurocognitive disorder with methamphetamine use

Stuart A. Lipton, Paschalis-Thomas Doulias, Tomohiro Nakamura, Henry Scott, Abdullah Sultan, Scott R. McKercher, Amanda Deal, Matthew Albertolle, Harry Ischiropoulos

Summary: Both HIV-1 and methamphetamine use lead to increased oxidative and nitrosative stress in the brain, potentially contributing to cognitive impairment and worsening effects of drug abuse. Enhanced S-nitrosylation of proteins derived from nitric oxide may disrupt protein activity, particularly impacting TCA enzymes and leading to energy collapse observed in HAND and methamphetamine use.

JOURNAL OF NEUROVIROLOGY (2021)

Article Multidisciplinary Sciences

Soluble α-synuclein-antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia

Dorit Trudler, Kristopher L. Nazor, Yvonne S. Eisele, Titas Grabauskas, Nima Dolatabadi, James Parker, Abdullah Sultan, Zhenyu Zhong, Marshall S. Goodwin, Yona Levites, Todd E. Golde, Jeffery W. Kelly, Michael R. Sierks, Nicholas J. Schork, Michael Karin, Rajesh Ambasudhan, Stuart A. Lipton

Summary: Parkinson's disease is associated with the accumulation of alpha-synuclein and activation of microglia, potentially leading to neuronal death. This study shows that alpha-synuclein can activate NLRP3 inflammasome in human microglia and that alpha-synuclein-antibody complexes can exacerbate inflammation in a human context.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Review Biochemistry & Molecular Biology

Protein S-nitrosylation and oxidation contribute to protein misfolding in neurodegeneration

Tomohiro Nakamura, Chang-ki Oh, Xu Zhang, Stuart A. Lipton

Summary: Neurodegenerative disorders such as Alzheimer's and Parkinson's diseases are characterized by progressive degeneration of synapses and neurons, often attributed to accumulated misfolded/aggregated proteins. Excessive reactive oxygen and nitrogen species in the brain may contribute to protein misfolding, potentially exacerbated by genetic mutations and environmental factors. Understanding the role of reactive nitrogen species in post-translational modifications of proteins could lead to therapeutic interventions for neurodegenerative diseases.

FREE RADICAL BIOLOGY AND MEDICINE (2021)

Article Immunology

Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation

Hongxu Xian, Yuan Liu, Alexandra Rundberg Nilsson, Raphaella Gatchalian, Timothy R. Crother, Warren G. Tourtellotte, Yi Zhang, German R. Aleman-Muench, Gavin Lewis, Weixuan Chen, Sarah Kang, Melissa Luevanos, Dorit Trudler, Stuart A. Lipton, Pejman Soroosh, John Teijaro, Juan Carlos de la Torre, Moshe Arditi, Michael Karin, Elsa Sanchez-Lopez

Summary: The study found that metformin can attenuate COVID-19-induced ARDS by inhibiting NLRP3 inflammasome activation, IL-1 beta and IL-6 secretion, and by blocking ATP and mtDNA synthesis.

IMMUNITY (2021)

Review Biochemistry & Molecular Biology

Emerging hiPSC Models for Drug Discovery in Neurodegenerative Diseases

Dorit Trudler, Swagata Ghatak, Stuart A. Lipton

Summary: Neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and Huntington's disease, represent a significant social and economic burden due to increasing prevalence and lack of effective therapies. Lack of reliable models has hindered the development of treatments, but human-induced pluripotent stem cell technology offers a promising alternative to complement animal models for disease modeling and drug discovery.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Neurosciences

S-Nitrosylation of p62 Inhibits Autophagic Flux to Promote α-Synuclein Secretion and Spread in Parkinson's Disease and Lewy Body Dementia

Chang-Ki Oh, Nima Dolatabadi, Piotr Cieplak, Maria T. Diaz-Meco, Jorge Moscat, John P. Nolan, Tomohiro Nakamura, Stuart A. Lipton

Summary: This article investigates the mechanism by which dysregulation of autophagic pathways leads to the accumulation of abnormal proteins and damaged organdies in neurodegenerative disorders. The authors found that pathologic protein S-nitrosylation of p62 is a critical factor for autophagic inhibition and cell-to-cell spread.

JOURNAL OF NEUROSCIENCE (2022)

Review Biochemistry & Molecular Biology

Potential Therapeutic Use of the Rosemary Diterpene Carnosic Acid for Alzheimer's Disease, Parkinson's Disease, and Long-COVID through NRF2 Activation to Counteract the NLRP3 Inflammasome

Takumi Satoh, Dorit Trudler, Chang-Ki Oh, Stuart A. Lipton

Summary: This article reviews the potential applications of carnosic acid (CA) and carnosol (CS) in rosemary for conditions such as Alzheimer's disease, Parkinson's disease, and COVID-19. It highlights the antioxidant, anti-inflammatory, and neuroprotective effects of CA, as well as its potential to inhibit the NLRP3 inflammasome. The article suggests that CA-related compounds could serve as therapeutics for acute and chronic neurological effects caused by SARS-CoV-2 infection and other neurodegenerative diseases.

ANTIOXIDANTS (2022)

Article Biochemistry & Molecular Biology

S-Nitrosylation of cathepsin B affects autophagic flux and accumulation of protein aggregates in neurodegenerative disorders

Ki-Ryeong Kim, Eun-Jung Cho, Jae-Won Eom, Sang-Seok Oh, Tomohiro Nakamura, Chang-ki Oh, Stuart A. Lipton, Yang-Hee Kim

Summary: This study reveals that S-nitrosylation of lysosomal protease cathepsin B (CTSB) inhibits its activity, blocks autophagic flux, and contributes to the pathogenesis of Alzheimer's disease (AD).

CELL DEATH AND DIFFERENTIATION (2022)

No Data Available